The severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) variant Omicron spread more rapid than the other variants of SARS-CoV-2 virus. Simulation results show that the Omicron Variant have stronger binding to ACE2 than other variants. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain Omicron Mutant 6VXX helps research…
Category: SARS-CoV-2
SARS-CoV-2 Receptor Binding Domain Delta Plus Mutant 6VXX
The SARS-CoV2 Delta Plus variant was first reported in India. This new variant, was shown to carry mutation K417N on its receptor-binding domain (RBD), a mutation previously reported in the Beta variant. Experts believe it contributes to immune evasion in SARS-CoV-2 and synergistic with mutation L452R, another mutation known to also contribute to immune evasion.…
SARS-CoV-2 Receptor Binding Domain ACE2 Complex 6M17
The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain (RBD) ACE2 Receptor Complex 6M17 to help research scientists and the general public better understand how SARS-CoV-2 binds ACE2 Receptors. (more…)
SARS-CoV-2 Receptor Binding Domain Antibody Complex 7KS9
The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain Neutralizing Antibody Complex 7KS9 to help research scientists and the general public better understand how to neutralize Spike Glycoprotein. (more…)
SARS-CoV-2 Receptor Binding Domain 6VXX
The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Receptor Binding Domain 6VXX to help research scientists and the general public better understand the binding properties of the Spike Glycoprotein and how it compares to other Coronavirus Spike Glycoproteins.…
SARS-CoV-2 Virion
The outbreak of a novel coronavirus (SARS-CoV-2) represents a pandemic threat that has been declared a public health emergency of international concern. The structural proteins of SARS-CoV-2 are key targets for vaccines, therapeutic antibodies, and diagnostics. The 3D printed structure of SARS-CoV-2 Virion should enable the rapid development and evaluation of medical countermeasures to address…
SARS-CoV-2 Spike Glycoprotein Antibody Complex 6VXX-7KS9
The outbreak of a novel coronavirus (SARS-CoV-2) represents a pandemic threat that has been declared a public health emergency of international concern. The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Spike Glycoprotein 7KS9 to help scientists better visualize…
SARS-CoV-2 Spike Glycoprotein Postfusion 6XRA
The outbreak of a novel coronavirus (SARS-CoV-2) represents a pandemic threat that has been declared a public health emergency of international concern. The SARS-CoV-2 Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. Biologic Models designed this 3D printed protein model of the SARS-CoV-2 Spike Glycoprotein Postfusion 6XRA to help scientists better…
SARS-CoV-2 Spike Glycoprotein ACE2 Complex 6VXX-6M17
The outbreak of a novel coronavirus (SARS-CoV-2) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV Spike Glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. The 3D printed structure of SARS-CoV-2 Spike Glycoprotein ACE2 Complex 6VXX-6M17 is designed to enable the rapid development and…
SARS-CoV-2 Spike Glycoprotein Prefusion 6VXX
SARS-CoV-2 RNA Polymerase inhibited by Remdesivir
The outbreak of a novel coronavirus (SARS-CoV-2) represents a pandemic threat that has been declared a public health emergency of international concern. The SARS-CoV-2 RNA Polymerase is a key target for antiviral therapy. The 3D printed structure of SARS-CoV-2 RNA Polymerase inhibited by Remdesivir should enable the rapid development and evaluation of medical countermeasures to address…